Cargando…
NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma
In our previous report, we identified miR-34c-3p as an independent factor contributing to the carcinogenesis of hepatocellular carcinoma (HCC) by targeting NCK Associated Protein 1 (NCKAP1). NCKAP1 has been known to promote the malignancy of cancer cells by disrupting the structural stability of WAS...
Autores principales: | Zhong, Xiao-ping, Kan, Anna, Ling, Yi-hong, Lu, Liang-he, Mei, Jie, Wei, Wei, Li, Shao-hua, Guo, Rong-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506474/ https://www.ncbi.nlm.nih.gov/pubmed/31068575 http://dx.doi.org/10.1038/s41419-019-1603-4 |
Ejemplares similares
-
NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma
por: Chen, Jiasheng, et al.
Publicado: (2022) -
Pan-cancer Analysis of the Disulfidptosis-related Gene NCKAP1 and Its Prognostic Value for Lung Adenocarcinoma
por: Zhu, Ankang, et al.
Publicado: (2023) -
NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation
por: Castro, Carla Noemi, et al.
Publicado: (2020) -
NCK-associated protein 1 like (nckap1l) minor splice variant regulates intrahepatic biliary network morphogenesis
por: Ghaffari, Kimia, et al.
Publicado: (2021) -
Role of NCKAP1 in the Defective Phagocytic Function of Microglia-Like Cells Derived from Rapidly Progressing Sporadic ALS
por: Noh, Min-Young, et al.
Publicado: (2023)